| [1] |
Slots J. Periodontitis：Facts，fallacies and the future[J]. Periodontol 2000， 2017，75（1）：7-23. DOI： 10.1111/prd.12221.
|
| [2] |
Lam GA， Albarrak H， Mccoll CJ，et al. The oral-gut axis：Periodontal diseases and gastrointestinal disorders[J]. Inflamm Bowel Dis， 2023， 29（7）：1153-1164. DOI： 10.1093/ibd/izac241.
|
| [3] |
Bao J， Li L， Zhang Y，et al. Periodontitis may induce gut microbiota dysbiosis via salivary microbiota[J]. Int J Oral Sci， 2022， 14（1）：32. DOI： 10.1038/s41368-022-00183-3.
|
| [4] |
Mi S， Cai S， Lou G，et al. Two-sample Mendelian randomization analysis of the relationship between periodontitis and risk of upper gastrointestinal cancers[J]. Postgrad Med J， 2024， 100（1189）：820-826. DOI： 10.1093/postmj/qgae069.
|
| [5] |
Sung H， Ferlay J， Siegel RL，et al. Global cancer statistics 2020：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin， 2021， 71（3）：209-249. DOI： 10.3322/caac.21660.
|
| [6] |
Uhlenhopp DJ， Then EO， Sunkara T，et al. Epidemiology of esophageal cancer：Update in global trends，etiology and risk factors[J]. Clin J Gastroenterol， 2020， 13（6）：1010-1021. DOI： 10.1007/s12328-020-01237-x.
|
| [7] |
Dar NA， Islami F， Bhat GA，et al. Poor oral hygiene and risk of esophageal squamous cell carcinoma in Kashmir[J]. Br J Cancer， 2013， 109（5）：1367-1372. DOI： 10.1038/bjc.2013.437.
|
| [8] |
Chen H， Nie S， Zhu Y，et al. Teeth loss，teeth brushing and esophageal carcinoma：A systematic review and Meta-analysis[J]. Sci Rep， 2015， 5（1）：15203. DOI： 10.1038/srep15203.
|
| [9] |
Chen QL， Zeng XT， Luo ZX，et al. Tooth loss is associated with increased risk of esophageal cancer：Evidence from a Meta-analysis with dose-response analysis[J]. Sci Rep， 2016， 6（1）：18900. DOI： 10.1038/srep18900.
|
| [10] |
Nozaki S， Sato Y， Takano H，et al. Pretreatment periodontitis is predictive of a poorer prognosis after esophagectomy for esophageal cancer[J]. Esophagus， 2024， 21（2）：120-130. DOI： 10.1007/s10388-024-01045-z.
|
| [11] |
Watanabe T， Sohda M， Kim M，et al. Preoperative evaluation of oral hygiene may predict the overall survival of patients with esophageal cancer[J]. Esophagus， 2023， 20（1）：99-108. DOI： 10.1007/s10388-022-00941-6.
|
| [12] |
Kwon MJ， Kang HS， Kim MJ，et al. Chronic periodontitis and the potential likelihood of gastric cancer：A nested case-control study in the korean population utilizing a national health sample cohort[J]. Cancers（Basel）， 2023， 15（15）：3974. DOI： 10.3390/cancers15153974.
|
| [13] |
Sasaki M， Shigeishi H， Nishi H，et al. Periodontitis and postoperative inflammation in gastric cancer patients：Propensity score analysis[J]. Oral Dis， 2024， 30（7）：4691-4704. DOI： 10.1111/odi.14865.
|
| [14] |
Sung CE， Lin FG， Huang RY，et al. Periodontitis， Helicobacter pylori infection，and gastrointestinal tract cancer mortality[J]. J Clin Periodontol， 2022， 49（3）：210-220. DOI： 10.1111/jcpe.13590.
|
| [15] |
Moradi Y， Majidi L， Khateri S，et al. The association between periodontal diseases and Helicobacter pylori：An updated meta-analysis of observational studies[J]. BMC Oral Health， 2023， 23（1）：523. DOI： 10.1186/s12903-023-03232-3.
|
| [16] |
Sekar R， Murali P， Junaid M. Quantification of Helicobacter pylori and its oncoproteins in the oral cavity：A cross-sectional study[J]. Oral Dis， 2023， 29（4）：1868-1874. DOI： 10.1111/odi.14141.
|
| [17] |
Chauhan N， Tay ACY， Marshall BJ，et al. Helicobacter pylori VacA，a distinct toxin exerts diverse functionalities in numerous cells：An overview[J]. Helicobacter， 2019， 24（1）：e12544. DOI： 10.1111/hel.12544.
|
| [18] |
Li R， Luo Y， Dong Q，et al. Association between the presence and genotype of Helicobacter pylori and periodontitis[J]. Exp Ther Med， 2023， 26（4）：489. DOI： 10.3892/etm.2023.12188.
|
| [19] |
Byun SH， Min C， Hong SJ，et al. Analysis of the relation between periodontitis and chronic gastritis/peptic ulcer：A cross-sectional study using KoGES HEXA data[J]. Int J Environ Res Public Health， 2020， 17（12）：4387. DOI： 10.3390/ijerph17124387.
|
| [20] |
Wang Y， Zhu J， Tang Y，et al. Association of periodontitis with gastrointestinal tract disorders：A bidirectional mendelian randomization study[J]. J Periodontol， 2024， 95（10）：1002-1010. DOI： 10.1002/JPER.23-0560.
|
| [21] |
Ozturk A. Periodontal treatment is associated with improvement in gastric Helicobacter pylori eradication：An updated Meta-analysis of clinical trials[J]. Int Dent J， 2021， 71（3）：188-196. DOI： 10.1111/idj.12616.
|
| [22] |
Chen X， Xian B， Wei J，et al. Predictive value of the presence of prevotella and the ratio of Porphyromonas gingivalis to prevotella in saliva for esophageal squamous cell carcinoma[J]. Front Cell Infect Microbiol， 2022， 12：997333. DOI： 10.3389/fcimb.2022.997333.
|
| [23] |
Maboudi A， Hajifathalian K， Negahban Z，et al. Correlation of Porphyromonas gingivalis with esophageal squamous cell carcinoma：A systematic review[J]. Clin Oral Investig， 2024， 29（1）：1. DOI： 10.1007/s00784-024-06094-3.
|
| [24] |
Gao SG， Qi ZP， Qi YJ，et al. Porphyromonas gingivalis predicts local recurrence after endoscopic submucosal dissection of early esophageal squamous cell carcinoma or precancerous lesion[J]. BMC Cancer， 2023， 23（1）：43. DOI： 10.1186/s12885-022-10469-8.
|
| [25] |
Zhang N， Liu Y， Yang H，et al. Clinical significance of Fusobacterium nucleatum infection and Tegulatory T cell enrichment in esophageal squamous cell carcinoma[J]. Pathol Oncol Res， 2021， 27：1609846. DOI： 10.3389/pore.2021.1609846.
|
| [26] |
Li Z， Shi C， Zheng J，et al. Fusobacterium nucleatum predicts a high risk of metastasis for esophageal squamous cell carcinoma[J]. BMC Microbiol， 2021， 21（1）：301. DOI： 10.1186/s12866-021-02352-6.
|
| [27] |
Zhang JW， Zhang D， Yin HS，et al. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression and chemoresistance by enhancing the secretion of chemotherapy-induced senescence-associated secretory phenotype via activation of DNA damage response pathway[J]. Gut Microbes， 2023， 15（1）：2197836. DOI： 10.1080/19490976.2023.2197836.
|
| [28] |
NIcolae FM， Didilescu AC， Şurlin P，et al. Subgingival periopathogens assessment and clinical periodontal evaluation of gastric cancer patients：A cross sectional pilot study[J]. Pathogens， 2022， 11（3）：360. DOI： 10.3390/pathogens11030360.
|
| [29] |
Chen WD， Zhang X， Zhang MJ，et al. Salivary Fusobacterium nucleatum serves as a potential diagnostic biomarker for gastric cancer[J]. World J Gastroenterol， 2022， 28（30）：4120-4132. DOI： 10.3748/wjg.v28.i30.4120.
|
| [30] |
Hsieh YY， Kuo WL， Hsu WT，et al. Fusobacterium nucleatum-induced tumor mutation burden predicts poor survival of gastric cancer patients[J]. Cancers， 2022， 15（1）：269. DOI： 10.3390/cancers15010269.
|
| [31] |
Petkevicius V， Lehr K， Kupcinskas J，et al. Fusobacterium nucleatum：Unraveling its potential role in gastric carcinogenesis[J]. World J Gastroenterol， 2024， 30（35）：3972-3984. DOI： 10.3748/wjg.v30.i35.3972.
|
| [32] |
Kadota T， Hamada M， Nomura R，et al. Distribution of Helicobacter pylori and periodontopathic bacterial species in the oral cavity[J]. Biomedicines， 2020， 8（6）：161. DOI： 10.3390/biomedicines8060161.
|
| [33] |
Hsieh YY， Tung SY， Pan HY，et al. Fusobacterium nucleatum colonization is associated with decreased survival of Helicobacter pylori-positive gastric cancer patients[J]. World J Gastroenterol， 2021， 27（42）：7311-7323. DOI： 10.3748/wjg.v27.i42.7311.
|
| [34] |
Lei J， Xu F， Deng C，et al. Fusobacterium nucleatum promotes the early occurrence of esophageal cancer through upregulation of IL-32/PRTN3 expression[J]. Cancer Sci， 2023， 114（6）：2414-2428. DOI： 10.1111/cas.15787.
|
| [35] |
Yu D， Yang J， Jin M，et al. Fecal streptococcus alteration is associated with gastric cancer occurrence and liver metastasis[J]. mBio， 2021， 12（6）：e0299421. DOI： 10.1128/mBio.02994-21.
|
| [36] |
Yang P， Liang G， Ni Y，et al. Investigating the role of intratumoral Streptococcus mitis in gastric cancer progression：Insights into tumor microenvironment[J]. J Transl Med， 2025， 23（1）：126. DOI： 10.1186/s12967-025-06142-w.
|
| [37] |
Yuan L， Pan L， Wang Y，et al. Characterization of the landscape of the intratumoral microbiota reveals that Streptococcus anginosus increases the risk of gastric cancer initiation and progression[J]. Cell Discov， 2024， 10（1）：117. DOI： 10.1038/s41421-024-00746-0.
|
| [38] |
Chen MF， Lu MS， Hsieh CC，et al. Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma[J]. Cell Oncol（Dordr）， 2021， 44（2）：373-384. DOI： 10.1007/s13402-020-00573-x.
|
| [39] |
|
| [40] |
Liang G， Wang H， Shi H，et al. Porphyromonas gingivalis promotes the proliferation and migration of esophageal squamous cell carcinoma through the miR-194/GRHL3/PTEN/akt axis[J]. ACS Infect Dis， 2020， 6（5）：871-881. DOI： 10.1021/acsinfecdis.0c00007.
|
| [41] |
Jia X， Liu J， He Y，et al. Porphyromonas gingivalis secretion leads to dysplasia of normal esophageal epithelial cells via the sonic hedgehog pathway[J]. Front Cell Infect Microbiol， 2022， 12：982636. DOI： 10.3389/fcimb.2022.982636.
|
| [42] |
Guo S， Chen F， Li L，et al. Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m 6A methylation to promote the metastasis of esophageal squamous cell carcinoma[J]. J Adv Res， 2024， 61：165-178. DOI： 10.1016/j.jare.2023.08.014.
|
| [43] |
Yin H， Zhang J， Zhang H，et al. Fusobacterium nucleatum promotes proliferation in oesophageal squamous cell carcinoma via AHR/CYP1A1 signalling[J]. FEBS J， 2023， 290（3）：837-854. DOI： 10.1111/febs.16619.
|
| [44] |
Xin Y， Li X， Zhang M，et al. Fusobacterium nucleatum-induced exosomal HOTTIP promotes gastric cancer progression through the microRNA-885-3p/EphB2 axis[J]. Cancer Sci， 2023， 114（6）：2360-2374. DOI： 10.1111/cas.15781.
|
| [45] |
Zhou T， Meng X， Wang D，et al. Neutrophil transcriptional deregulation by the periodontal pathogen Fusobacterium nucleatum in gastric cancer：A bioinformatic study[J]. Dis Markers， 2022：9584507. DOI： 10.1155/2022/9584507.
|
| [46] |
Gao S， Liu Y， Duan X，et al. Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapy[J]. Br J Cancer， 2021， 125（3）：433-444. DOI： 10.1038/s41416-021-01419-5.
|
| [47] |
|
| [48] |
|
| [49] |
Oriuchi M， Lee S， Uno K，et al. Porphyromonas gingivalis lipopolysaccharide damages mucosal barrier to promote gastritis-associated carcinogenesis[J]. Dig Dis Sci， 2024， 69（1）：95-111. DOI： 10.1007/s10620-023-08142-6.
|
| [50] |
Kosumi K， Baba Y， Yamamura K，et al. Intratumour Fusobacterium nucleatum and immune response to oesophageal cancer[J]. Br J Cancer， 2023， 128（6）：1155-1165. DOI： 10.1038/s41416-022-02112-x.
|
| [51] |
Liang M， Liu Y， Zhang Z，et al. Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells，leading to cisplatin resistance[J]. Ann Med， 2022， 54（1）：989-1003. DOI： 10.1080/07853890.2022.2061045.
|
| [52] |
Hara Y， Baba Y， Oda E，et al. Presence of Fusobacterium nucleatum in relation to patient survival and an acidic environment in oesophagogastric junction and gastric cancers[J]. Br J Cancer， 2024， 131（5）：797-807. DOI： 10.1038/s41416-024-02753-0.
|
| [53] |
Li Y， Xing S， Chen F，et al. Intracellular Fusobacterium nucleatum infection attenuates antitumor immunity in esophageal squamous cell carcinoma[J]. Nat Commun， 2023， 14（1）：5788. DOI： 10.1038/s41467-023-40987-3.
|
| [54] |
Liu Y， Baba Y， Ishimoto T，et al. Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma[J]. Br J Cancer， 2021， 124（5）：963-974. DOI： 10.1038/s41416-020-01198-5.
|
| [55] |
Meng X， Ma G， Zhang X，et al. Extracellular vesicles from Fusobacterium nucleatum：Roles in the malignant phenotypes of gastric cancer[J]. Cell Cycle， 2024， 23（3）：294-307. DOI： 10.1080/15384101.2024.2324587.
|